A Community-Based Approach to Democratize the Diagnosis of Pediatric Acute Lymphoblastic Leukemia (ALL)

By: Reishel Sulivan Lope Paredes, COAR Ayacucho (Peru)

This review article and proposal addresses the inequity in the diagnosis and treatment of pediatric Acute Lymphoblastic Leukemia (ALL) in low resource regions, such as the interior of Peru, and to extend it throughout Latin America. Because survival can be less than 60% in Peru, in contrast to more than 90% in developed countries, I propose a theoretical solution, BioLEAP, as a new option for early and rapid detection and influence new numbers that are encouraging to continue the fight against cancer.

View paper
Previous
Previous

Digital Literacy Gaps and Telehealth Equity: A Bibliometric Analysis of Elderly Engagementin Digital Chronic Disease Management

Next
Next

The Role of Chromosomal Aberration in Recurrent Pregnancy Loss (RPL)